Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric

In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.03, down -0.99% from the previous session. RXRX stock price is now -10.82% away from the 50-day moving average and -22.50% away from the 200-day moving average. The market capitalization of the company currently stands at $2.33B. With the price target of $8, […]

The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -0.43% lower at $6.95 on Wall Street last session. RXRX stock price is now 3.35% away from the 50-day moving average and -12.18% away from the 200-day moving average. The market capitalization of the company currently stands at $2.69B. With the price target of $8, Morgan Stanley recently initiated […]

Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric

Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 5.26% to $6.00. RXRX stock price is now -9.13% away from the 50-day moving average and -27.58% away from the 200-day moving average. The market capitalization of the company currently stands at $2.31B. With the price target of $8, Morgan Stanley […]

Stocks like Recursion Pharmaceuticals Inc [RXRX] still have plenty of sunny days ahead

In yesterday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.32, down -5.39% from the previous session. RXRX stock price is now -5.16% away from the 50-day moving average and -26.17% away from the 200-day moving average. The market capitalization of the company currently stands at $1.84B. With the price target of $8, […]

The most important numbers to know about Recursion Pharmaceuticals Inc (NASDAQ:RXRX)

The stock of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) last traded at $6.36, up 0.47% from the previous session. RXRX stock price is now -5.21% away from the 50-day moving average and -26.68% away from the 200-day moving average. The market capitalization of the company currently stands at $1.85B. With the price target of $8, Morgan Stanley […]